Related Experiment Video
Updated: Oct 25, 2025

07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
6.1K
Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?
Alessandro Fugazza1, Edoardo Troncone2, Arnaldo Amato3
1Digestive Endoscopy Unit, Departement of Gastroenterology, Humanitas Research Hospital-IRCCS, Rozzano, Italy.
Summary
Difficult biliary cannulation (DBC) is common in patients with distal malignant biliary obstruction (DMBO), occurring in over half of cases. DBC increases the risk of adverse events during ERCP, necessitating alternative biliary drainage techniques.
Area of Science:
- Gastroenterology
- Interventional Endoscopy
- Oncology
Background:
- Failed biliary cannulation is a significant challenge during Endoscopic Retrograde Cholangiopancreatography (ERCP).
- Limited data exists on the rate of Difficult Biliary Cannulation (DBC) specifically in patients with distal malignant biliary obstruction (DMBO).
Purpose of the Study:
- To determine the rate of DBC in patients with DMBO undergoing ERCP.
- To identify secondary outcomes including cannulation failure, adverse events (AEs), and predictive factors for DBC and AEs.
Main Methods:
- Retrospective analysis of 622 patients with DMBO undergoing ERCP across four Italian centers (09/2015-02/2019).
- Primary outcome: rate of DBC. Secondary outcomes: cannulation failure, AEs, and predictive factors.
Main Results:
- A high rate of DBC was observed, affecting 351 (56.4%) of patients.
- ERCP-related AEs occurred in 15.6% of patients, with DBC patients showing a higher risk (p=0.02).
- Factors associated with AEs included lack of pancreatitis prophylaxis, cholangiocarcinoma diagnosis, use of papillotomy, and multiple cannulation techniques.
Conclusions:
- Patients with DMBO experience a high rate of DBC, often requiring alternative biliary drainage methods.
- DBC is associated with an increased risk of adverse events.
- Further prospective multicentric studies are recommended to validate these findings in this patient subgroup.

